ArticleFrontiers in immunology2025

Combining immune-related adverse events and inflammatory profiles enhances prognostic accuracy in metastatic melanoma under PD-1-based therapy.

Dionysios Garmpis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.